Wichterman Troy
- SEC CIK
- 0001892616
In the past year, 6 open-market sale filings worth $873.5K and no purchases.
Current role at each company
- BLFS Biolife Solutions IncChief Financial Officeras of Sep 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $873.5K
- 6 filings
- Net
- −$873.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wichterman Troy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2022 (view filing) | Mar 22 | 2 days | Wichterman TroyChief Financial Officer | SSale | −551 | $23.06 | −$12.7K | −1.2%44.1K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Wichterman TroyChief Financial Officer | SSale | −56 | $23.78 | −$1.33K | −0.3%21.3K after | |
| Feb 17, 2022 (view filing) | Nov 30, 2021 | 79 days | Wichterman TroyChief Financial Officer | SSale | −33 | $37.59 | −$1.24K | −0.1%22.4K after | Amended |
| Feb 17, 2022 (view filing) | Dec 22, 2021 | 57 days | Wichterman TroyChief Financial Officer | SSale | −310 | $38.49 | −$11.9K | −1.4%22.1K after | Amended |
| Feb 17, 2022 (view filing) | Jan 7 | 41 days | Wichterman TroyChief Financial Officer | SSale | −47 | $30.75 | −$1.45K | −0.2%22.1K after | Amended |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Wichterman TroyChief Financial Officer | SSale | −695 | $26.57 | −$18.5K | −3.1%21.4K after |